Search

everythinglearnresearchcommunity

for

Search:↓

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Lupus erythematosus can mimic alopecia areata, and trichoscopy is key for accurate diagnosis and better patient outcomes.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

A woman with lupus had rare severe symptoms but improved with treatment.

Probiotics may help improve symptoms in rheumatoid arthritis patients.

Methotrexate and azathioprine can help treat alopecia areata.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

AQB reduces harmful skin changes in systemic sclerosis.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Atopic diseases worsen alopecia areata, leading to earlier onset and more severe forms.

Autoimmune Polyendocrine Syndromes involve specific combinations of autoimmune diseases.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Juvenile-onset lupus patients have more severe symptoms and need stronger treatment.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

A young woman with visual issues and other symptoms was diagnosed with lupus and antiphospholipid syndrome, and improved with treatment.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

Alopecia is common in lupus patients, causing significant anxiety and is linked to the disease itself.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.